<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03063775</url>
  </required_header>
  <id_info>
    <org_study_id>7333</org_study_id>
    <nct_id>NCT03063775</nct_id>
  </id_info>
  <brief_title>Proof of Concept: Socket Seal</brief_title>
  <acronym>SocketSeal</acronym>
  <official_title>Proof of Concept: Intra-oral Soft Tissue Preservation of Extraction Sockets in Anterior Upper Jaw</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is planned to evaluate if a porcine collagen matrix (Mucograft Seal) is offering
      comparable results to free gingival grafts (FGG) in post-extraction tissue preservation. If
      so, this would provide a substantial benefit to the patient as the second intervention on the
      palate and the subsequent morbidity of the donor site is omitted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a proof of concept 5 groups are compared in preserving soft- and hard tissue after tooth
      extraction in the esthetic zone:

        1. Mucograft® Seal + Bio-Oss®

        2. Free Gingival Graft (FGG) + Bio-Oss®

        3. Free Gingival Graft + Gelatine sponge (Spongostan®)

        4. Spongostan®+ Mucograft® Seal

        5. Spongostan®

      Volumetric changes of hard and soft tissues are recorded , 2/4/8 weeks and 3/6/12 months
      after extraction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Soft tissue volume</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Soft tissue volume</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Soft tissue volume</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone volume</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone volume</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone volume</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tissue Preservation</condition>
  <arm_group>
    <arm_group_label>1. Mucograft® Seal + Bio-Oss®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2. FGG + Bio-Oss®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3. FGG + Gelatine sponge (Spongostan®)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4. Spongostan®+ Mucograft® Seal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>5. Spongostan®</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioOss® + Mucograft Seal®</intervention_name>
    <description>Placement of BioOss®-Collagen into the extraction socket. The Mucograft Seal® Membrane is then applied to the socket.</description>
    <arm_group_label>1. Mucograft® Seal + Bio-Oss®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FGG + Bio-Oss®</intervention_name>
    <description>Placement of BioOss®-Collagen into the extraction socket. The FGG is then attached to the socket.</description>
    <arm_group_label>2. FGG + Bio-Oss®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FGG + Gelatine sponge (Spongostan®)</intervention_name>
    <description>Placement of a Gelatine sponge into the extraction socket, then attaching the FGG to the socket.</description>
    <arm_group_label>3. FGG + Gelatine sponge (Spongostan®)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spongostan®+ Mucograft® Seal</intervention_name>
    <description>Placement of a Gelatine sponge into the extraction socket, then attaching the Mucograft® Seal Membrane to the socket</description>
    <arm_group_label>4. Spongostan®+ Mucograft® Seal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Planned extraction in the upper front or premolar region

        Exclusion Criteria:

          -  General risk situation (antiresorptive therapy, antiangiogenic therapy, history of
             local radiation therapy, heavy coagulation disorder, relevant allergies, dysregulated
             Diabetes mellitus, malignant diseases)

          -  Acute gingivitis

          -  Deep pockets (&gt;5.5mm)

          -  Apical periodontitis on neighboring teeth

          -  Heavy smoker (&gt;10/d)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Rugani, DDS, DMSc</last_name>
      <phone>+4331638580339</phone>
      <email>petra.rugani@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Michael Payer, PhD, MD, DDS</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2017</study_first_submitted>
  <study_first_submitted_qc>February 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2017</study_first_posted>
  <last_update_submitted>February 21, 2017</last_update_submitted>
  <last_update_submitted_qc>February 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrin Foam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

